Related Experiment Video
Updated: Jun 7, 2026

The Influence of Liver Resection on Intrahepatic Tumor Growth
Published on: April 9, 2016
Impact of obesity on children undergoing liver transplantation
André A S Dick1, James D Perkins, Austin L Spitzer
1Division of Transplantation, Department of Surgery, University of Washington, Seattle, WA 98195, USA. docdre@u.washington.edu
Insights
Pediatric liver transplant survival is impacted by body mass index (BMI). Thin children face early mortality, while obese children experience increased late mortality risks following liver transplantation.
Area of Science:
- Pediatric Surgery
- Transplant Surgery
- Clinical Outcomes Research
Background:
- Liver transplantation outcomes can be affected by extremes in body mass index (BMI).
- Pediatric liver transplant survival analyses traditionally focus on weight, not BMI-adjusted Z scores.
Purpose of the Study:
- To investigate the association between BMI Z scores and survival rates in pediatric liver transplant recipients.
- To identify differential mortality risks associated with underweight and overweight/obese status in pediatric liver transplant patients.
Main Methods:
- Analysis of the United Network for Organ Sharing database (1987-2007) including 9701 pediatric primary liver transplants.
- Stratification of patients into 5 BMI-for-age Z score categories (WHO standards).
- Comparison of survival rates using Kaplan-Meier curves and log-rank testing.
Main Results:
- Thin pediatric patients (Z score -2 or -3) showed significantly lower 1-year survival (84.4%) compared to normal/overweight groups (88.7%).
- Obese pediatric patients (Z score +3) had no early survival difference, but experienced significantly lower 12-year survival (72%) versus normal/overweight groups (77%).
Conclusions:
- Liver transplantation poses increased risks for both underweight and obese pediatric patients.
- Underweight patients face early mortality, whereas obese patients face late mortality post-transplant.
- Tailored transplant management strategies are needed to optimize care for pediatric patients at BMI extremes.
Abstract:
Controversies exist with respect to the mortality of patients undergoing liver transplantation at the extremes of the body mass index (BMI). For pediatric liver transplantation, weight is usually the only factor considered in survival analysis. A review of the United Network for Organ Sharing database (1987-2007) revealed 9701 pediatric patients (<18 years old) who underwent primary liver transplantation. Patients were stratified into 5 BMI categories established by the World Health Organization according to their Z score, which was based on age, gender, and BMI: -3, -2, 0, +2, and +3. The survival rates in these 5 categories were compared with Kaplan-Meier survival curves and log-rank testing. Patients with thinness (Z score = -2) and severe thinness (Z score = -3) had significantly (P < 0.0001) lower survival at 1 year (84.4%) versus the survival (88.7%) of the normal and overweight groups (Z score = 0 and Z score = + 2, respectively). For patients with obesity (Z score = +3), there was no significant difference in survival early after transplantation, but their mortality gradually increased in the later years after transplantation. By 12 years after liver transplantation, the obese group had significantly (P = 0.04) lower survival (72%) than the normal and overweight groups (77%). In conclusion, liver transplantation holds increased risk for obese pediatric patients. Thin pediatric patients experience early mortality after liver transplantation, and obese pediatric patients experience late mortality after liver transplantation. Transplant management can be modified to optimize the care of these patients.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Kidney Transplant I: Introduction
Drug Dosing: Obese Patients
Obesity
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

